Phase 1Recruiting

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Sponsored by Rhythm Pharmaceuticals, Inc.

About this study

The purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment

Enrolling at this location

Ann and Robert H. Lurie Children's Hospital of Chicago (Part C and Part D)

Chicago, Illinois

I'm interested

This study also enrolls at 6 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.